Clinical trials
Observational Dementia trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2008 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 1 |
| 2022 | 2 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 6 |
| Unknown status | 6 |
| Recruiting | 5 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Technical University of Munich | 2 |
| Universitätsklinikum Hamburg-Eppendorf | 2 |
| Charite University, Berlin, Germany | 1 |
| Fondazione Europea di Ricerca Biomedica Ferb Onlus | 1 |
| German Center for Neurodegenerative Diseases (DZNE) | 1 |
| Hannover Medical School | 1 |
| INVADE gGmbH | 1 |
| Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 1 |
| Ludwig-Maximilians - University of Munich | 1 |
| Max-Planck-Institute of Psychiatry | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dementia | 18 |
| Alzheimer Disease | 9 |
| Cognitive Dysfunction | 9 |
| Stroke | 4 |
| Dementia, Vascular | 3 |
| Neurocognitive Disorders | 2 |
| Psychophysiologic Disorders | 2 |
| Anxiety Disorders | 1 |
| Brain Ischemia | 1 |
| Cerebral Small Vessel Diseases | 1 |
Trials
Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.